Evidence map›Paper›PMID 11283262›Full record

ArticleMolecular and cellular biology2001

The peptide near the C terminus regulates receptor CAR nuclear translocation induced by xenochemicals in mouse liver.

I Zelko, T Sueyoshi, T Kawamoto, R Moore, M Negishi

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 147 citations in OpenAlex.

  1. Phenobarbital in Nuclear Receptor Activation: An Update.Drug metabolism and disposition: the biological fate of chemicals · 2023
    Review
  2. Identifying CAR Modulators Utilizing a Reporter Gene Assay.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  3. Noncanonical Constitutive Androstane Receptor Signaling in Gene Regulation.International journal of molecular sciences · 2020
    Review
  4. Article
  5. The Roles of Xenobiotic Receptors: Beyond Chemical Disposition.Drug metabolism and disposition: the biological fate of chemicals · 2018
    Review
  6. Article
  7. Article
  8. Phenobarbital Meets Phosphorylation of Nuclear Receptors.Drug metabolism and disposition: the biological fate of chemicals · 2017
    Article
  9. Review
  10. Regulation of PXR and CAR by protein-protein interaction and signaling crosstalk.Expert opinion on drug metabolism & toxicology · 2016
    Review
  11. Small-molecule modulators of PXR and CAR.Biochimica et biophysica acta · 2016
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Role of CAR and PXR in xenobiotic sensing and metabolism.Expert opinion on drug metabolism & toxicology · 2012
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

I ZelkoPharmacogenetics Section, Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709, USA.
T Sueyoshi
T Kawamoto
R Moore
M Negishi
National Institute of Environmental Health Sciences · USNational Institutes of Health · US

Funding

Mechanisms and biological consequences of the nuclear receptor CAR activationZIAES080040 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI NEGISHI, MASAHIKO · 2009 to 2020
$35.3M
Pharmacogenetics Of Microsomal Steroid HydroxylasesZ01ES080040 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI NEGISHI, MASAHIKO · 1985 to 2008
$5.7M
6 · The paper itself

Abstract

In response to phenobarbital (PB) and other PB-type inducers, the nuclear receptor CAR translocates to the mouse liver nucleus (T. Kawamoto et al., Mol. Cell. Biol. 19:6318-6322, 1999). To define the translocation mechanism, fluorescent protein-tagged human CAR (hCAR) was expressed in the mouse livers using the in situ DNA injection and gene delivery systems. As in the wild-type hCAR, the truncated receptor lacking the C-terminal 10 residues (i.e., AF2 domain) translocated to the nucleus, indicating that the PB-inducible translocation is AF2 independent. Deletion of the 30 C-terminal residues abolished the receptor translocation, and subsequent site-directed mutagenesis delineated the PB-inducible translocation activity of the receptor to the peptide L313GLL316AEL319. Ala mutations of Leu313, Leu316, or Leu319 abrogated the translocation of CAR in the livers, while those of Leu312 or Leu315 did not affect the nuclear translocation. The leucine-rich peptide dictates the nuclear translocation of hCAR in response to various PB-type inducers and appears to be conserved in the mouse and rat receptors.

Indexed as

Amino Acid SequenceAnimalsBiological Transport, ActiveCell LineCell NucleusConstitutive Androstane ReceptorGreen Fluorescent ProteinsHumansLiverLuminescent ProteinsMiceMolecular Sequence DataMutagenesis, Site-DirectedPhenobarbitalRatsReceptors, Cytoplasmic and NuclearConstitutive Androstane ReceptorGreen Fluorescent ProteinsLuminescent ProteinsPhenobarbitalReceptors, Cytoplasmic and NuclearRecombinant Fusion ProteinsTranscription FactorsXenobiotics

Identifiers

PMID11283262
PMCPMC86913
OpenAlexW2008467936

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.